GlobeNewswire Inc | Sep 10, 2021 08:45AM EDT

September 10, 2021

REDWOOD CITY, Calif., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc.(Coherus, Nasdaq: CHRS), today announced that senior management will present at the 23rd Annual H.C. Wainwright Global Investment Conference. The presentation will be made available at 7 a.m. ET on Tuesday, September 14, 2021, during the virtual conference.

The audio portion of the presentation will be available on the investors page of the Coherus Biosciences website at http://investors.coherus.com.

About Coherus BioSciencesCoherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients lives and to deliver significant savings to the health care system. Coherus strategy is to build a leading immuno-oncology franchise funded with cash generated by its commercial biosimilar business. For additional information, please visit www.coherus.com.

Coherus Contact Information:IR Contact:McDavid StilwellCoherus BioSciences, Inc.mstilwell@coherus.com+1 (650) 395-0152

Media Contact:Sheryl SeapyReal Chemistrysseapy@realchemistry.com+1 (949) 903-4750